Skip to content

Treatment of cutaneous leishmaniasis with thymol loaded chitosan gel

Evaluation of the treatment of cutaneous leishmaniasis with thymol loaded chitosan gel, as topical supplemental therapy (A RCT study)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180526039848N1
Enrollment
50
Registered
2020-07-12
Start date
2020-04-08
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous leishmaniasis. Cutaneous leishmaniasis

Interventions

Intervention 1: Intervention Group 1: Includes ten people with 2% chitosan gel in one of the wounds plus glucantime to increase the effectiveness compared to the other wound of the patient who is trea

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: There are at least two lesions, in one case intervention + glucantime and in the other lesion only glucantime is prescribed. 15 to 60 years Skin lesions at least one centimeter in size Leishmaniasis confirmed by a parasitologist consent signature

Exclusion criteria

Exclusion criteria: People who do not use the drug according to the plan People who do not go to the clinic on the scheduled days

Design outcomes

Primary

MeasureTime frame
Measuring the lesion diameter (millimeters) using image processing software. Timepoint: From the first week of treatment and patient visit the clinic for the first time (once every three days to 45 days). Method of measurement: processing software.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBibi Razieh Hosseini Farash

Mashhad University of Medical Sciences

HoseiniFR@mums.ac.ir+98 51 3800 2454

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026